JP2010502564A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010502564A5 JP2010502564A5 JP2009507259A JP2009507259A JP2010502564A5 JP 2010502564 A5 JP2010502564 A5 JP 2010502564A5 JP 2009507259 A JP2009507259 A JP 2009507259A JP 2009507259 A JP2009507259 A JP 2009507259A JP 2010502564 A5 JP2010502564 A5 JP 2010502564A5
- Authority
- JP
- Japan
- Prior art keywords
- ophthalmic
- preparation according
- agents
- percutaneous absorption
- absorption preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000010521 absorption reaction Methods 0.000 claims 5
- 239000000043 antiallergic agent Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 229940124597 therapeutic agent Drugs 0.000 claims 4
- 239000003732 agents acting on the eye Substances 0.000 claims 3
- 229940023490 ophthalmic product Drugs 0.000 claims 3
- 239000005526 vasoconstrictor agent Substances 0.000 claims 3
- 208000026062 Tissue disease Diseases 0.000 claims 2
- 230000003449 preventive effect Effects 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- ZCVMWBYGMWKGHF-UHFFFAOYSA-N Ketotifene Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 ZCVMWBYGMWKGHF-UHFFFAOYSA-N 0.000 claims 1
- HVRLZEKDTUEKQH-NOILCQHBSA-N Olopatadine hydrochloride Chemical compound Cl.C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 HVRLZEKDTUEKQH-NOILCQHBSA-N 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000000030 antiglaucoma agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000002554 disease preventive effect Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229960003449 epinastine Drugs 0.000 claims 1
- WHWZLSFABNNENI-UHFFFAOYSA-N epinastine Chemical compound C1C2=CC=CC=C2C2CN=C(N)N2C2=CC=CC=C21 WHWZLSFABNNENI-UHFFFAOYSA-N 0.000 claims 1
- 210000000744 eyelid Anatomy 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 229960004958 ketotifen Drugs 0.000 claims 1
- 229960003630 ketotifen fumarate Drugs 0.000 claims 1
- YNQQEYBLVYAWNX-WLHGVMLRSA-N ketotifen fumarate Chemical group OC(=O)\C=C\C(O)=O.C1CN(C)CCC1=C1C2=CC=CC=C2CC(=O)C2=C1C=CS2 YNQQEYBLVYAWNX-WLHGVMLRSA-N 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 229960004114 olopatadine Drugs 0.000 claims 1
- JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 claims 1
- 229960003139 olopatadine hydrochloride Drugs 0.000 claims 1
- 229960003733 phenylephrine hydrochloride Drugs 0.000 claims 1
- OCYSGIYOVXAGKQ-FVGYRXGTSA-N phenylephrine hydrochloride Chemical group [H+].[Cl-].CNC[C@H](O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-FVGYRXGTSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84046206P | 2006-08-28 | 2006-08-28 | |
| PCT/JP2007/067103 WO2008026756A1 (en) | 2006-08-28 | 2007-08-28 | Ophthalmic percutaneous absorption type preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010502564A JP2010502564A (ja) | 2010-01-28 |
| JP2010502564A5 true JP2010502564A5 (https=) | 2010-10-14 |
Family
ID=38669015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009507259A Pending JP2010502564A (ja) | 2006-08-28 | 2007-08-28 | 眼科用経皮吸収型製剤 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090318422A1 (https=) |
| EP (1) | EP2056809A1 (https=) |
| JP (1) | JP2010502564A (https=) |
| KR (1) | KR20090042956A (https=) |
| CN (1) | CN101528211B (https=) |
| WO (1) | WO2008026756A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009074853A2 (en) * | 2007-12-10 | 2009-06-18 | Promed Research Centre | Ophthalmic composition comprising phenylephrine |
| JP5458798B2 (ja) * | 2008-10-27 | 2014-04-02 | 大正製薬株式会社 | フマル酸ケトチフェン含有眼科用剤 |
| US9034830B2 (en) | 2009-10-30 | 2015-05-19 | Intratus, Inc. | Methods and compositions for sustained delivery of drugs |
| US8900626B2 (en) | 2011-06-20 | 2014-12-02 | Senju Usa, Inc. | Transdermal drug delivery system and method of using the same |
| US9510972B2 (en) * | 2012-01-04 | 2016-12-06 | Sight Sciences, Inc. | Dry eye treatment systems |
| JP6062705B2 (ja) * | 2012-10-19 | 2017-01-18 | ロート製薬株式会社 | 医薬組成物 |
| KR101688061B1 (ko) * | 2014-10-06 | 2017-01-02 | 주식회사한국파마 | 필로카르핀 경피 흡수 제제 |
| KR20240023714A (ko) * | 2015-02-02 | 2024-02-22 | 산텐 세이야꾸 가부시키가이샤 | 폴리아프론 및 이의 안검 투여 |
| US9820954B2 (en) * | 2015-08-19 | 2017-11-21 | Jenivision Inc. | Quantitative peri-orbital application of ophthalmology drugs |
| CN107823124B (zh) * | 2017-11-09 | 2018-11-27 | 广州博济医药生物技术股份有限公司 | 一种盐酸奥洛他定外用组合物及其乳膏剂 |
| WO2019133690A1 (en) * | 2017-12-28 | 2019-07-04 | Nichiban Co., Ltd. | Transdermal drug delivery system and method for using same |
| CA3092966A1 (en) | 2018-03-02 | 2019-09-06 | The Schepens Eye Research Institute | System and method for treating meibomian gland dysfunction |
| JP7458159B2 (ja) * | 2018-09-28 | 2024-03-29 | ロート製薬株式会社 | 眼科組成物 |
| US20220160668A1 (en) | 2020-11-23 | 2022-05-26 | Sight Sciences, Inc. | Formulations and methods for treating conditions of the eye |
| US20240074973A1 (en) * | 2020-12-24 | 2024-03-07 | Santen Pharmaceutical Co., Ltd. | Pharmaceutical composition for topical administration containing epi-nastine or salt thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2899235A (en) * | 1959-08-11 | Folding van body | ||
| JPH0780760B2 (ja) * | 1986-07-28 | 1995-08-30 | ライオン株式会社 | 安定化されたフエニレフリン系液剤 |
| JP2001354561A (ja) * | 1993-04-01 | 2001-12-25 | Fujisawa Pharmaceut Co Ltd | 局所投与製剤 |
| US5862931A (en) * | 1995-12-29 | 1999-01-26 | Cox; Charles F. | Collapsible shipping container |
| AU7081598A (en) * | 1997-04-24 | 1998-11-13 | Taisho Pharmaceutical Co., Ltd. | Eye drops |
| DE60132325T2 (de) * | 2000-05-17 | 2009-01-02 | Senju Pharmaceutical Co., Ltd. | Ophthalmische lösung |
| JP2002308764A (ja) * | 2001-02-09 | 2002-10-23 | Taisho Pharmaceut Co Ltd | 眼科用医薬組成物 |
| JP2003073303A (ja) * | 2001-09-05 | 2003-03-12 | Senju Pharmaceut Co Ltd | 眼局所用液剤の清涼化作用の持続方法 |
| US6811048B2 (en) * | 2002-02-12 | 2004-11-02 | David M. K. Lau | Fold-up storage container |
| JP2004143156A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 点眼剤 |
| JP2004143154A (ja) * | 2002-10-01 | 2004-05-20 | Taisho Pharmaceut Co Ltd | 点眼剤 |
| KR20050092429A (ko) * | 2003-01-22 | 2005-09-21 | 니찌방 가부시기가이샤 | 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법 |
| DE602005019724D1 (de) * | 2004-05-21 | 2010-04-15 | Senju Pharma Co | Ophthalmologische perkutan absorbierbare zubereitung enthaltend einen muscarin-rezeptor-agonist |
| JP2006052160A (ja) * | 2004-08-10 | 2006-02-23 | Rohto Pharmaceut Co Ltd | ドライアイ治療用眼科組成物 |
| US7296704B2 (en) * | 2004-08-11 | 2007-11-20 | Ferrini Jonathan B | Collapsible container |
| CN101123948A (zh) * | 2005-02-17 | 2008-02-13 | 千寿制药株式会社 | 眼科用固体外用药剂 |
| ES2437077T3 (es) * | 2005-07-08 | 2014-01-08 | Senju Pharmaceutical Co., Ltd. | Preparado oftálmico de absorción percutánea que comprende olopatadina |
| CN101217948A (zh) * | 2005-07-08 | 2008-07-09 | 千寿制药株式会社 | 包含依匹那丁的透皮吸收眼科制剂 |
| US7823739B2 (en) * | 2006-12-08 | 2010-11-02 | C Cubed I Llc | Collapsible shipping container |
-
2007
- 2007-08-28 EP EP07806576A patent/EP2056809A1/en not_active Withdrawn
- 2007-08-28 US US12/310,281 patent/US20090318422A1/en not_active Abandoned
- 2007-08-28 JP JP2009507259A patent/JP2010502564A/ja active Pending
- 2007-08-28 WO PCT/JP2007/067103 patent/WO2008026756A1/en not_active Ceased
- 2007-08-28 CN CN2007800402421A patent/CN101528211B/zh not_active Expired - Fee Related
- 2007-08-28 KR KR1020097004893A patent/KR20090042956A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010502564A5 (https=) | ||
| ES2997337T3 (en) | Composition for use in the prevention or suppression of myopia | |
| ES2377253T3 (es) | Neramexano para uso en el tratamiento de tinitus subagudo | |
| ES2393211T3 (es) | Uso de 2-aminotetralinas sustituidas para la fabricación de un medicamento para la prevención, alivio y/o tratamiento de diversos tipos de dolor | |
| US9980927B2 (en) | Use of tapentadol for inhibiting and/or treating depression and anxiety | |
| ES2374336T3 (es) | Agente profiláctico o terapéutico para una enfermedad ocular posterior que comprende un agonista selectivo no ergótico del receptor d2 como principio activo. | |
| Bisht et al. | Ototoxicity: the hidden menace | |
| ES2239196T3 (es) | Suministro iontoforetico de rotigotina para el tratamiento de la enfermedad de parkinson. | |
| JP2011510014A5 (https=) | ||
| HRP20120798T1 (hr) | Kappa-opijatni agonisti za lijeäśenje dijareja-predominantnog i naizmjeniäśnog sindroma iritabilnog crijeva | |
| JP2015503417A (ja) | ドライアイ治療システム | |
| JP2009501797A5 (https=) | ||
| AU2007245983A1 (en) | Use of escitalopram for improving cognition | |
| RU2011146032A (ru) | Соединения-агонисты рецептора 5-ht4 для лечения расстройств познавательной способности | |
| ES2236551T3 (es) | Combinacion de principios activos para el tratamiento medico de toxicomanias. | |
| KR20210125507A (ko) | 수면성 무호흡의 치료 방법 및 조성물 | |
| TW200744574A (en) | Use of L-carnitine or of alkanoyl L-carnitines for the preparation of a physiological supplement of medicament for ophthalmic use in the form of eye-drops | |
| CN102066402A (zh) | 肽衍生物以及含有肽衍生物的用于促进泪液分泌的组合物 | |
| ES2348314T3 (es) | Derivados de mononitrato de isosorbida para el tratamiento de la hipertensión ocular. | |
| JP2007527417A5 (https=) | ||
| WO2013184650A3 (en) | Treatment of ocular inflammatory diseases using laquinimod | |
| JP2015523986A5 (https=) | ||
| WO2005113002A1 (ja) | ムスカリン受容体作動薬を含有する眼科用経皮吸収型製剤 | |
| ES2656313T3 (es) | Uso de derivados de amida cíclica para tratar trastornos del sueño | |
| JP2009500398A5 (https=) |